Africa
Global organizations are calling for an increase in diagnostic tests — particularly point-of-care molecular assays — to meet the challenge of a new outbreak.
C2N Diagnostics and Unilabs Ink Deal to Sell Precivity Alzheimer's Dx in Europe, Other Geographies
Unilabs will offer the Precivity tests on an exclusive basis in countries including Norway, Switzerland, the UK, Peru, Saudi Arabia, and the United Arab Emirates.
Gates Foundation Awards Multiple Omics, Dx Grants in July
Awardees include PATH, Prolific Machines, the Liverpool School of Tropical Medicine, Wits Health Consortium, Washington University in St. Louis, and Cedars-Sinai.
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.